363 related articles for article (PubMed ID: 28046096)
21. Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment.
Mehta SR; Pérez-Santiago J; Hulgan T; Day TR; Barnholtz-Sloan J; Gittleman H; Letendre S; Ellis R; Heaton R; Patton S; Suben JD; Franklin D; Rosario D; Clifford DB; Collier AC; Marra CM; Gelman BB; McArthur J; McCutchan A; Morgello S; Simpson D; Connor J; Grant I; Kallianpur A
J Neuroinflammation; 2017 Mar; 14(1):72. PubMed ID: 28359324
[TBL] [Abstract][Full Text] [Related]
22. Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B.
de Almeida SM; Rotta I; Jiang Y; Li X; Raboni SM; Ribeiro CE; Smith D; Potter M; Vaida F; Letendre S; Ellis RJ;
J Neurovirol; 2016 Dec; 22(6):715-724. PubMed ID: 27400932
[TBL] [Abstract][Full Text] [Related]
23. Replication of Human Herpesviruses Is Associated with Higher HIV DNA Levels during Antiretroviral Therapy Started at Early Phases of HIV Infection.
Gianella S; Anderson CM; Var SR; Oliveira MF; Lada SM; Vargas MV; Massanella M; Little SJ; Richman DD; Strain MC; Pérez-Santiago J; Smith DM
J Virol; 2016 Apr; 90(8):3944-3952. PubMed ID: 26842469
[TBL] [Abstract][Full Text] [Related]
24. Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia.
Schnell G; Spudich S; Harrington P; Price RW; Swanstrom R
PLoS Pathog; 2009 Apr; 5(4):e1000395. PubMed ID: 19390619
[TBL] [Abstract][Full Text] [Related]
25. Very Early Initiation of Antiretroviral Therapy During Acute HIV Infection Is Associated With Normalized Levels of Immune Activation Markers in Cerebrospinal Fluid but Not in Plasma.
Hellmuth J; Slike BM; Sacdalan C; Best J; Kroon E; Phanuphak N; Fletcher JLK; Prueksakaew P; Jagodzinski LL; Valcour V; Robb M; Ananworanich J; Allen IE; Krebs SJ; Spudich S
J Infect Dis; 2019 Nov; 220(12):1885-1891. PubMed ID: 30668739
[TBL] [Abstract][Full Text] [Related]
26. Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study.
Gisslén M; Price RW; Andreasson U; Norgren N; Nilsson S; Hagberg L; Fuchs D; Spudich S; Blennow K; Zetterberg H
EBioMedicine; 2016 Jan; 3():135-140. PubMed ID: 26870824
[TBL] [Abstract][Full Text] [Related]
27. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.
Henrich TJ; Hatano H; Bacon O; Hogan LE; Rutishauser R; Hill A; Kearney MF; Anderson EM; Buchbinder SP; Cohen SE; Abdel-Mohsen M; Pohlmeyer CW; Fromentin R; Hoh R; Liu AY; McCune JM; Spindler J; Metcalf-Pate K; Hobbs KS; Thanh C; Gibson EA; Kuritzkes DR; Siliciano RF; Price RW; Richman DD; Chomont N; Siliciano JD; Mellors JW; Yukl SA; Blankson JN; Liegler T; Deeks SG
PLoS Med; 2017 Nov; 14(11):e1002417. PubMed ID: 29112956
[TBL] [Abstract][Full Text] [Related]
28. Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy.
Gianella S; Kosakovsky Pond SL; Oliveira MF; Scheffler K; Strain MC; De la Torre A; Letendre S; Smith DM; Ellis RJ
Virus Evol; 2016 Jul; 2(2):vew020. PubMed ID: 27774305
[TBL] [Abstract][Full Text] [Related]
29. HIV-1 Central Nervous System Compartmentalization and Cytokine Interplay in Non-Subtype B HIV-1 Infections in Nigeria and Malawi.
Adewumi OM; Dukhovlinova E; Shehu NY; Zhou S; Council OD; Akanbi MO; Taiwo B; Ogunniyi A; Robertson K; Kanyama C; Hosseinipour MC; Swanstrom R
AIDS Res Hum Retroviruses; 2020 Jun; 36(6):490-500. PubMed ID: 31914800
[TBL] [Abstract][Full Text] [Related]
30. Circulating HIV DNA Correlates With Neurocognitive Impairment in Older HIV-infected Adults on Suppressive ART.
de Oliveira MF; Murrell B; Pérez-Santiago J; Vargas M; Ellis RJ; Letendre S; Grant I; Smith DM; Woods SP; Gianella S
Sci Rep; 2015 Nov; 5():17094. PubMed ID: 26603568
[TBL] [Abstract][Full Text] [Related]
31. Treatment intensification has no effect on the HIV-1 central nervous system infection in patients on suppressive antiretroviral therapy.
Yilmaz A; Verhofstede C; D'Avolio A; Watson V; Hagberg L; Fuchs D; Svennerholm B; Gisslén M
J Acquir Immune Defic Syndr; 2010 Dec; 55(5):590-6. PubMed ID: 20847699
[TBL] [Abstract][Full Text] [Related]
32. What can characterization of cerebrospinal fluid escape populations teach us about viral reservoirs in the central nervous system?
Joseph SB; Trunfio M; Kincer LP; Calcagno A; Price RW
AIDS; 2019 Dec; 33 Suppl 2():S171-S179. PubMed ID: 31790378
[TBL] [Abstract][Full Text] [Related]
33. Higher Anti-Cytomegalovirus Immunoglobulin G Concentrations Are Associated With Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy.
Letendre S; Bharti A; Perez-Valero I; Hanson B; Franklin D; Woods SP; Gianella S; de Oliveira MF; Heaton RK; Grant I; Landay AL; Lurain N;
Clin Infect Dis; 2018 Aug; 67(5):770-777. PubMed ID: 29506084
[TBL] [Abstract][Full Text] [Related]
34. Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders.
McGuire JL; Gill AJ; Douglas SD; Kolson DL;
J Neurovirol; 2015 Aug; 21(4):439-48. PubMed ID: 25776526
[TBL] [Abstract][Full Text] [Related]
35. Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection.
Schnell G; Price RW; Swanstrom R; Spudich S
J Virol; 2010 Mar; 84(5):2395-407. PubMed ID: 20015984
[TBL] [Abstract][Full Text] [Related]
36. Neurocognitive Impairment in the Combined Antiretroviral Therapy Era in a Romanian Cohort of Young Adults with Chronic HIV Infection.
Temereanca A; Ene L; Rosca A; Diaconu CC; Luca A; Burlacu R; Radoi R; Bulacu-Talnariu A; Marcotte TD; Achim CL; Ruta S
AIDS Res Hum Retroviruses; 2020 May; 36(5):367-372. PubMed ID: 31476875
[TBL] [Abstract][Full Text] [Related]
37. A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadir.
Piketty C; Weiss L; Assoumou L; Burgard M; Mélard A; Ragnaud JM; Bentata M; Girard PM; Rouzioux C; Costagliola D;
J Med Virol; 2010 Nov; 82(11):1819-28. PubMed ID: 20872707
[TBL] [Abstract][Full Text] [Related]
38. Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients.
Antinori A; Giancola ML; Grisetti S; Soldani F; Alba L; Liuzzi G; Amendola A; Capobianchi M; Tozzi V; Perno CF
AIDS; 2002 Sep; 16(14):1867-76. PubMed ID: 12351946
[TBL] [Abstract][Full Text] [Related]
39. Cerebrospinal fluid (CSF) CD8+ T-cells that express interferon-gamma contribute to HIV associated neurocognitive disorders (HAND).
Schrier RD; Hong S; Crescini M; Ellis R; Pérez-Santiago J; Spina C; Letendre S;
PLoS One; 2015; 10(2):e0116526. PubMed ID: 25719800
[TBL] [Abstract][Full Text] [Related]
40. Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA.
Gianella S; von Wyl V; Fischer M; Niederoest B; Battegay M; Bernasconi E; Cavassini M; Rauch A; Hirschel B; Vernazza P; Weber R; Joos B; Günthard HF;
Antivir Ther; 2011; 16(4):535-45. PubMed ID: 21685541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
